Shana Claeys
No current affiliation with UGent
- ORCID iD
-
0000-0002-1332-2653
Show
Sort by
-
- Journal Article
- A1
- open access
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
-
ALK positively regulates MYCN activity through repression of HBP1 expression
-
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
-
TBX2 is implicated in cell cycle control and proliferation in neuroblastoma
-
The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma
-
The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma
-
- Journal Article
- A1
- open access
A high-throughput 3’ UTR reporter screening identifies microRNA interactomes of cancer genes
-
- PhD Thesis
- open access
Identification of novel drug targets downstream of activated ALK in neuroblastoma
(2018) -
The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma
-
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex